Narrow Your Results
Abbvie-M14-730 (EXPEDITION 2) ABT-493/ABT-530 in Chronic Hepatitis C and HIV study (PRO00003794)
The purpose of this study is to assess the efficacy and safety of ABT-493/ABT-530 in adults with chronic hepatitis C virus genotype 1-6 infection and human immunodeficiency virus-1 co-infection.
AI444-046 Asunaprevir Long-Term Follow-Up Study (PRO00002268)
The primary purpose of this study is to determine whether the hepatitis C virus continues to remain unable to be detected in subjects who were previously treated with Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) and achieved sustained virologic response.
Chronic Hepatitis Long-Term Follow-Up Study (PRO00002808)
The purposes of this research study are: 1) test the long-term safety of the research study drug, MK-5172; 2) evaluate how long a sustained virologic response (SVR) will last after treatment with MK-5172; and 3) evaluate the characteristics of mutated forms of the HCV, if any are found, that are known or suspected to be resistant to MK-5172.
Label Validation Study (PRO00003257)
The purpose of this research study is see if the directions for the Intercept® i2he™ Oral Fluid Collection Device give enough information to collect the sample correctly.
OQHIV-M-1 Investigation of Early Read Times (PRO00003151)
The purpose of this research study is to use finger stick blood samples and/or oral fluid samples to see how early a test line can be seen in the OraQuick ADVANCE Rapid HIV-1/2 Antibody Test and OraQuick Rapid HIV-1/2 Antibody Test.
HIV Viral Load Testing (PRO00000054)
The primary purpose of this research study is to develop novel microchip-based testing for following patients with HIV positive disease, and to compare these microchip-based testing to existing testing for HIV.